APA (7th ed.) Citation

ER, C., RT, K., DK, W., JM, H., MX, R., JE, C., . . . PG, S. (2020). Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity. JAMA ophthalmology, 138(1), 14. https://doi.org/10.1001/jamaophthalmol.2019.4488

Chicago Style (17th ed.) Citation

ER, Crouch, et al. "Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity." JAMA Ophthalmology 138, no. 1 (2020): 14. https://doi.org/10.1001/jamaophthalmol.2019.4488.

MLA (9th ed.) Citation

ER, Crouch, et al. "Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity." JAMA Ophthalmology, vol. 138, no. 1, 2020, p. 14, https://doi.org/10.1001/jamaophthalmol.2019.4488.